en
Scientific article
English

Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome

Published inClinical oncology, vol. 26, no. 6, p. 316-322
Publication date2014
Abstract

To evaluate the tolerance and preliminary outcome of prostate cancer patients at high risk of lymph node involvement treated with normofractionated whole pelvic radiotherapy (WPRT) followed by a hypofractionated boost to the prostate with an intensity-modulated radiotherapy (IMRT) technique.

Citation (ISO format)
ZILLI, Thomas et al. Hypofractionated external beam radiotherapy to boost the prostate with ≥85 Gy/equivalent dose for patients with localised disease at high risk of lymph node involvement: feasibility, tolerance and outcome. In: Clinical oncology, 2014, vol. 26, n° 6, p. 316–322. doi: 10.1016/j.clon.2014.02.014
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal0936-6555
505views
1downloads

Technical informations

Creation12/23/2014 10:37:00 AM
First validation12/23/2014 10:37:00 AM
Update time03/14/2023 10:33:40 PM
Status update03/14/2023 10:33:39 PM
Last indexation01/16/2024 3:31:38 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack